Document text
Principal Investigator: ALEXANDER PLETNEV
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2022
Award: $675,862
Funding agency: National Institute of Allergy and Infectious Diseases
The pathogenesis of flaviviral neuroinfection is complex and depends on a series of events involving (1) virus replication in the periphery to produce and sustain the level of viremia sufficient for neuroinvasion, (2) virus entry into the CNS (neuroinvasiveness), (3) virus replication, spread, and introduction of neuropathology once in the CNS (neurovirulence), and (4) virus-mediated stimulation of innate and adaptive immune responses of the host both in the periphery and within the CNS. To prevent the virus entry into the CNS (neuroinvasiveness) and to restrict its replication in the neurons (neurovirulence) or in peripheral organs, we have explored several different approaches and developed the vaccine candidates using the strategies based on (1) chimerization of a neurovirulent virus (JEV, WNV, SLEV or TBEV) with a non-neuroinvasive mosquito-borne dengue type 4 flavivirus (DEN4) or naturally attenuated tick-borne Langat virus (LGT) and (2) targeting of viral genome for cellular microRNAs (miRNAs) expressed in the tissue of interest (etc., brain, reproductive organs, placenta) for selective control of virus tropism. The promising and most attenuated vaccine candidates were then evaluated for safety, immunogenicity, and their ability to protect mice and monkeys against challenge with wild-type virulent parental virus. In addition, a miRNA targeting approach was adapted to design environmentally safe vaccine viruses restricted in their ability to infect and be transmitted by permissive arthropod vectors (mosquitoes or ticks).
West Nile virus (WNV) is a mosquito-borne neurotropic flavivirus that has emerged as a human pathogen of global scale and now is a leading cause of viral encephalitis in US. There are no approved vaccines against WNV, clinical management of the disease in humans remains only supportive, and our current understanding of the disease neuropathogenesis is yet to be translated into effective treatments. Building on our methodological approaches and recent findings that helped to fill the gaps in our understanding of WNV neuropathogenesis in nonhuman primates, in FYI 2022 we initiated efforts to obtain the brain and spinal cord tissues from human cases of WNV encephalitis in the US. We are working on the design and implementation of multiple studies to address the outstanding questions regarding WNV neuropathogenesis and its short- and long-term impacts on humans. To address these questions, we engage multiple colleagues from the NIAID Division of Intramural Research and Research Technology Branch (both in Bethesda, Maryland and Hamilton, Montana) to employ informative existing and emerging methodologies including histopathology, immunohistochemistry, digital pathology, electron microscopy, transcriptomics, in situ RNA detection, and spatial protein profiling. We hope that new findings using integration of these scientific approaches may provide a better understanding of the pathophysiology of the disease of the central nervous system caused by WNV infection and prompt a new thinking in a search for effective therapeutic approaches.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Address><Arboviral><Arboviruses><Arthropod Vectors><Arthropod-Borne Viruses><Arthropoda><Arthropods><Attention><Attenuated><Attenuated Live Virus Vaccine><Attenuated Vaccines><Body Tissues><Brain><Brain Nervous System><CHIKV><CNS Diseases><CNS Nervous System><CNS disorder><COVID-19 virus><COVID19 virus><Cells Placenta-Tissue><Central Nervous System><Central Nervous System Diseases><Central Nervous System Disorders><Characteristics><Chikungunya virus><Clinical Management><CoV-2><CoV2><Complex><Dengue><Detection><Development><Disease><Disease Management><Disease Outbreaks><Disorder><Disorder Management><Dysfunction><Egypt 101 virus><Electron Microscopy><Encephalon><Epidemic><Event><Family><Flaviviridae><Flavivirus><Functional disorder><Goals><Group B Arbovirus><Histopathology><Human><Immune response><Immunohistochemistry><Immunohistochemistry Cell/Tissue><Immunohistochemistry Staining Method><Immunological response><Impairment><In Situ><Infection><Intramural Research><Invaded><Ixodida><Japanese B Encephalitis Virus><Japanese Population><Japanese encephalitis virus><Japanese group><Japanese individual><Japanese people><Knowledge><Langat virus><Live-attenuated Vaccine><Maryland><Mediating><Medical><Medulla Spinalis><Methodology><Mice><Mice Mammals><Micro RNA><MicroRNAs><Modern Man><Monkeys><Montana><Murine><Mus><NIAID><National Institute of Allergy and Infectious Disease><Nerve Cells><Nerve Unit><Nervous System Diseases><Neural Cell><Neuraxis><Neurocyte><Neurologic><Neurologic Disorders><Neurological><Neurological Disorders><Neurons><Neuropathogenesis><Non-Polyadenylated RNA><Normal Placentoma><Organ><Outbreaks><Pathogenesis><Pathogenicity><Peripheral><Physiopathology><Placenta><Placenta Embryonic Tissue><Placentome><R-Series Research Projects><R01 Mechanism><R01 Program><RNA><RNA Gene Products><RNA Viruses><Research Grants><Research Project Grants><Research Projects><Ribonucleic Acid><Route><SARS Virus><SARS corona virus><SARS corona virus 2><SARS coronavirus><SARS-Associated Coronavirus><SARS-CO-V2><SARS-COVID-2><SARS-CoV><SARS-CoV-1><SARS-CoV-2><SARS-CoV2><SARS-Related Coronavirus><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Safety><Saint Louis Encephalitis><Series><Severe Acute Respiratory Coronavirus><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Sexual Transmission><Spinal Cord><St. Louis Encephalitis><St. Louis Viral Encephalitis><Technology><Testicles><Testis><Thinking><Tick-Borne Encephalitis Virus><Tickborne Encephalitis Virus><Ticks><Tissues><Translating><Transmission><Type C Lethargic Encephalitis><Vaccines><Viral Encephalitis><Viral Genome><Viral Infectious Encephalomyelitis><Viremia><Virulent><Virus><Virus Replication><WNV><West Nile><West Nile Encephalitis><West Nile Virus Pathway><West Nile viral infection><West Nile virus><West Nile virus encephalitis><West Nile virus infection><Wuhan coronavirus><ZIKV><ZIKV infection><ZIKV positive><ZIKV vaccine><Zika Virus><Zika vaccine><Zika virus infection><Zika virus vaccine><adaptive immune response><base><coronavirus disease 2019 virus><coronavirus disease-19 virus><design><designing><develop a vaccine><develop vaccines><development of a vaccine><developmental><digital pathology><effective therapy><effective treatment><emerging pathogen><genital tract><hCoV19><host response><human pathogen><human tissue><immune system response><immunogenicity><immunoresponse><interest><live vaccine><live vaccines><male><member><miRNA><miRNAs><mosquito-borne><mosquitoborne><nCoV2><nervous system disorder><neurological disease><neuronal><neuropathology><neurotropic><neurovirulence><new approaches><new pathogen><non-human primate><nonhuman primate><novel approaches><novel pathogen><novel strategies><novel strategy><pandemic><pandemic disease><pathogen><pathophysiology><prevent><preventing><protein profiling><reproductive organ><reproductive tract><severe acute respiratory syndrome-CoV><sexually transmitted><therapeutically effective><thoughts><tick-borne><tickborne><tissue tropism><transcriptomics><transmission process><vaccine candidate><vaccine development><vector mosquito><viraemia><viral multiplication><viral replication><viral sepsis><virus genome><virus multiplication><virus tropism><virusemia><zika infection><zika viral infection><zikav>